Berkeley, CA
Actym Therapeutics, based in Berkeley, CA, is a privately-held biotechnology company focused on discovery and development of novel immuno-oncology therapies to treat cancer. The company has developed an attenuated, microbial-based, immunotherapeutic technology platform called STACT (S. Typhimurium-A... Read more
actymthera.comThese are collections Actym Therapeutics is a part of. Click on the collection name to view similar companies.
Series A
$25,500,000
Series A
$34,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Actym Therapeutics.